Canntab Therapeutics gets first commercial sale with Medipharm
Canntab Therapeutics (CSE: PILL- OTCQB: CTABF) CFO Richard Goldstein and Special Advisor Larry Latowsky joined Steve Darling from Proactive Vancouver with news the company has signed their first contract for their slow release tablets with MediPharm.
Goldstein discusses how the deal with work and what is it worth to the company. Meanwhile, Latowsky discusses, why he is joining the company and what he sees as the big advantages Canntab, has over others.
Goldstein discusses how the deal with work and what is it worth to the company. Meanwhile, Latowsky discusses, why he is joining the company and what he sees as the big advantages Canntab, has over others.
People In This Video
No users are tagged in this video